Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12217361rdf:typepubmed:Citationlld:pubmed
pubmed-article:12217361lifeskim:mentionsumls-concept:C0019169lld:lifeskim
pubmed-article:12217361lifeskim:mentionsumls-concept:C0282519lld:lifeskim
pubmed-article:12217361lifeskim:mentionsumls-concept:C1174433lld:lifeskim
pubmed-article:12217361lifeskim:mentionsumls-concept:C0243072lld:lifeskim
pubmed-article:12217361pubmed:issue19lld:pubmed
pubmed-article:12217361pubmed:dateCreated2002-9-9lld:pubmed
pubmed-article:12217361pubmed:abstractText2,5-Pyridinedicarboxylic acid derivatives were found to be the potent non-nucleoside inhibitors of hepatitis B virus (HBV) with IC(50) <or=0.01 microg/mL in a reverse transcriptase inhibitory effect. And they showed the low toxicity compared with the nucleoside analogues.lld:pubmed
pubmed-article:12217361pubmed:languageenglld:pubmed
pubmed-article:12217361pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12217361pubmed:citationSubsetIMlld:pubmed
pubmed-article:12217361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12217361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12217361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12217361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12217361pubmed:statusMEDLINElld:pubmed
pubmed-article:12217361pubmed:monthOctlld:pubmed
pubmed-article:12217361pubmed:issn0960-894Xlld:pubmed
pubmed-article:12217361pubmed:authorpubmed-author:LeeJinSooJlld:pubmed
pubmed-article:12217361pubmed:authorpubmed-author:ShimHyungSooHlld:pubmed
pubmed-article:12217361pubmed:authorpubmed-author:ParkYongKyunYlld:pubmed
pubmed-article:12217361pubmed:authorpubmed-author:ParkSangJinSlld:pubmed
pubmed-article:12217361pubmed:authorpubmed-author:ShinJoonSuJlld:pubmed
pubmed-article:12217361pubmed:authorpubmed-author:YangWangYongWlld:pubmed
pubmed-article:12217361pubmed:authorpubmed-author:LeeHakDongHlld:pubmed
pubmed-article:12217361pubmed:authorpubmed-author:ParkWhuiJungWlld:pubmed
pubmed-article:12217361pubmed:authorpubmed-author:ChungYongHoYlld:pubmed
pubmed-article:12217361pubmed:authorpubmed-author:LeeSangWookSlld:pubmed
pubmed-article:12217361pubmed:issnTypePrintlld:pubmed
pubmed-article:12217361pubmed:day7lld:pubmed
pubmed-article:12217361pubmed:volume12lld:pubmed
pubmed-article:12217361pubmed:ownerNLMlld:pubmed
pubmed-article:12217361pubmed:authorsCompleteYlld:pubmed
pubmed-article:12217361pubmed:pagination2715-7lld:pubmed
pubmed-article:12217361pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12217361pubmed:meshHeadingpubmed-meshheading:12217361...lld:pubmed
pubmed-article:12217361pubmed:meshHeadingpubmed-meshheading:12217361...lld:pubmed
pubmed-article:12217361pubmed:meshHeadingpubmed-meshheading:12217361...lld:pubmed
pubmed-article:12217361pubmed:meshHeadingpubmed-meshheading:12217361...lld:pubmed
pubmed-article:12217361pubmed:meshHeadingpubmed-meshheading:12217361...lld:pubmed
pubmed-article:12217361pubmed:meshHeadingpubmed-meshheading:12217361...lld:pubmed
pubmed-article:12217361pubmed:year2002lld:pubmed
pubmed-article:12217361pubmed:articleTitle2,5-Pyridinedicarboxylic acid derivatives as non-nucleosidic reverse transcriptase inhibitors of hepatitis B virus.lld:pubmed
pubmed-article:12217361pubmed:affiliationCentral Research Laboratory, DongWha Pharm. Ind. Co. Ltd., Seoul, South Korea.lld:pubmed
pubmed-article:12217361pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12217361pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:12217361lld:chembl